Esperion Therapeutics Inc. (ESPR)
NASDAQ · Healthcare
Esperion Therapeutics Inc. annual/quarterly shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Esperion Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were -302.0M, a 22.32% decrease year-over-year.
- Esperion Therapeutics Inc. shareholder equity for 2025 were -302.0M, a 22.32% decrease from 2024.
- Esperion Therapeutics Inc. shareholder equity for 2024 were -388.7M, a 14.57% decrease from 2023.
- Esperion Therapeutics Inc. shareholder equity for 2023 were -455.0M, a 40.53% increase from 2022.
- Esperion Therapeutics Inc. shareholder equity for 2022 were -323.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Esperion Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-302 |
| 2024 | $-389 |
| 2023 | $-455 |
| 2022 | $-324 |
| 2021 | $-197 |
| 2020 | $-96 |
| 2019 | $20 |
| 2018 | $79 |
| Esperion Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-302 |
| 2024-12-31 | $-389 |
| 2023-12-31 | $-455 |
| 2022-12-31 | $-324 |
| 2021-12-31 | $-197 |
| 2020-12-31 | $-96 |
| 2019-12-31 | $20 |
| 2018-12-31 | $79 |
Esperion Therapeutics Inc. Shareholder Equity — FAQ
Esperion Therapeutics Inc. (ESPR) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ESPR's shareholder equity history?
The chart and table above show Esperion Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.